ID   HPC-Y21
AC   CVCL_A069
DR   cancercelllines; CVCL_A069
DR   Cosmic; 730524
DR   Wikidata; Q54890257
RX   PubMed=7961102;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=7961102).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (PubMed=7961102).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 11
//
RX   PubMed=7961102; DOI=10.1111/j.1349-7006.1994.tb02898.x; PMCID=PMC5919355;
RA   Suwa H., Yoshimura T., Yamaguchi N., Kanehira K., Manabe T.,
RA   Imamura M., Hiai H., Fukumoto M.;
RT   "K-ras and p53 alterations in genomic DNA and transcripts of human
RT   pancreatic adenocarcinoma cell lines.";
RL   Jpn. J. Cancer Res. 85:1005-1014(1994).
//